Extracellular matrix and extracellular matrix-derived materials in reproductive medicine
Review of ECM in reproductive medicine
DOI:
https://doi.org/10.54844/prm.2022.0142Keywords:
extracellular matrix, reproductive medicine, tissue engineeringAbstract
Infertility has become a worldwide issue, and many patients cannot benefit from assisted reproductive technologies (ART). The extracellular matrix (ECM) is critical in tissue organization and remodeling. The female reproductive system plays an important role in menstruation, pregnancy, and ovulation and may influence fertility. In addition, ECM has a wide variety of components, good biological properties, and extensive application experience as a biomaterial. In-depth research on the ECM in the female reproductive system and the development and application of ECM-derived materials may provide new ideas for solving infertility problems. This review aimed to summarize the regulation and changes of ECM in the uterus and ovary, and to discuss the progress of research on ECM-derived materials in reproductive tissue engineering. An extensive search in PubMed and Embase was conducted using keywords including extracellular matrix, uterus, ovary, tissue engineering, and material. We are devoted to combining research on ECM-derived materials with clinical practice and intend to provide ideas for solving clinical problems in reproductive medicine.
References
Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10.
Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366.
Palermo G, Joris H, Devroey P, van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340(8810):17–18.
Karamanos NK, Theocharis AD, Piperigkou Z, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288(24):6850–6912.
O’Connor BB, Pope BD, Peters MM, Ris-Stalpers C, Parker KK. The role of extracellular matrix in normal and pathological pregnancy: future applications of microphysiological systems in reproductive medicine. Exp Biol Med (Maywood). 2020;245(13):1163–1174.
Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884–886.
Bedaiwy MA, Shahin AY, Falcone T. Reproductive organ transplantation: advances and controversies. Fertil Steril. 2008;90(6):2031–2055.
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009;5(1):1–13.
Gelse K, Pöschl E, Aigner T. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531–1546.
Vasvani S, Kulkarni P, Rawtani D. Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int J Biol Macromol. 2020;151:1012–1029.
Wen Q, Mithieux SM, Weiss AS. Elastin biomaterials in dermal repair. Trends Biotechnol. 2020;38(3):280–291.
Vindin H, Mithieux SM, Weiss AS. Elastin architecture. Matrix Biol. 2019;84:4–16.
Almine JF, Bax DV, Mithieux SM, et al. Elastin-based materials. Chem Soc Rev. 2010;39(9):3371–3379.
Aumailley M. The laminin family. Cell Adh Migr. 2013;7(1):48–55.
Yurchenco PD, McKee KK, Reinhard JR, Rüegg MA. Laminin-deficient muscular dystrophy: molecular pathogenesis and structural repair strategies. Matrix Biol. 2018;71–72:174–187.
Patten J, Wang K. Fibronectin in development and wound healing. Adv Drug Deliv Rev. 2021;170:353–368.
Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997;91(4):439–442.
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827–839.
Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008;29(5):258–289.
Mead TJ, Apte SS. ADAMTS proteins in human disorders. Matrix Biol. 2018;71–72:225–239.
Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A. 1962;48(6):1014–1022.
Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.
Zitka O, Kukacka J, Krizkova S, et al. Matrix metalloproteinases. Curr Med Chem. 2010;17(31):3751–3768.
Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44–46:247–254.
Ågren MS, Schnabel R, Christensen LH, Mirastschijski U. Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo. Eur J Cell Biol. 2015;94(1):12–21.
Mirastschijski U, Lupše B, Maedler K, et al. Matrix metalloproteinase-3 is key effector of TNF-α-induced collagen degradation in skin. Int J Mol Sci. 2019;20(20):5234.
Li X, Guo L, Yang X, et al. TGF-β1-induced connexin43 promotes scar formation via the Erk/MMP-1/collagen III pathway. J Oral Rehabil. 2020;47(Suppl 1):99–106.
Chen LC, Shibu MA, Liu CJ, et al. ERK1/2 mediates the lipopolysaccharideinduced upregulation of FGF-2, uPA, MMP-2, MMP-9 and cellular migration in cardiac fibroblasts. Chem Biol Interact. 2019;306:62–69.
Salamonsen LA, Zhang J, Hampton A, Lathbury L. Regulation of matrix metalloproteinases in human endometrium. Hum Reprod. 2000;15(Suppl3):112–119.
Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod. 1996;11(Suppl 2):124–133.
Obokata A, Watanabe J, Nishimura Y, Arai T, Kawaguchi M, Kuramoto H. Significance of matrix metalloproteinase-7[correction of matrix metalloproteinase-2],-11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Anticancer Res. 2007;27(1A):95–105.
Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253(1):269–285.
Yoshii N, Hamatani T, Inagaki N, et al. Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity. Reprod Biol Endocrinol. 2013;11:37.
Basu J, Agamasu E, Bendek B, et al. Correlation Between Placental Matrix Metalloproteinase 9 and Tumor Necrosis Factor-α Protein Expression Throughout Gestation in Normal Human Pregnancy. Reprod Sci. 2018;25(4):621–627.
Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 2002;87(3):1353–1361.
Wang W, Vilella F, Alama P, et al. Single-cell transcriptomic atlas of the human endometrium during the menstrual cycle. Nat Med. 2020;26(10):1644–1653.
Sternberg AK, Buck VU, Classen-Linke I, Leube RE. How mechanical forces change the human endometrium during the menstrual cycle in preparation for embryo implantation. Cells. 2021;10(8):2008.
Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22(4):497–515.
Burrows TD, King A, Smith SK, Loke YW. Human trophoblast adhesion to matrix proteins: inhibition and signal transduction. Hum Reprod. 1995;10(9):2489–2500.
Sinai Talaulikar V, Kronenberger K, Bax BE, Moss R, Manyonda I. Differences in collagen ultrastructure of human first trimester decidua basalis and parietalis: implications for trophoblastic invasion of the placental bed. J Obstet Gynaecol Res. 2014;40(1):80–88.
Tanaka T, Wang C, Umesaki N. Remodeling of the human endometrial epithelium is regulated by laminin and type IV collagen. Int J Mol Med. 2009;23(2):173–180.
Yang ZS, Pan HY, Shi WW, et al. Regulation and function of laminin A5 during mouse and human decidualization. Int J Mol Sci. 2021;23(1):199.
Sanders B. Uterine factors and infertility. J Reprod Med. 2006;51(3):169–176.
Liu KE, Hartman M, Hartman A. Management of thin endometrium in assisted reproduction: a clinical practice guideline from the Canadian Fertility and Andrology Society. Reprod Biomed Online. 2019;39(1):49–62.
Berman JM. Intrauterine adhesions. Semin Reprod Med. 2008;26(4):349–355.
Nejat EJ, Zapantis G, Rybak EA, Meier UT. It’s time to pay attention to the endometrium, including the nucleolar channel system. Fertil Steril. 2011;96(6):e165;authorreplye166.
Jiang P, Tang X, Wang H, et al. Collagen-binding basic fibroblast growth factor improves functional remodeling of scar red endometrium in uterine infertile women: a pilot study. Sci China Life Sci. 2019;62(12):1617–1629.
Cimadomo D, Craciunas L, Vermeulen N, Vomstein K, Toth B. Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists. Hum Reprod. 2021;36(2):305–317.
Turpeenniemi-Hujanen T, Feinberg RF, Kauppila A, Puistola U. Extracellular matrix interactions in early human embryos: implications for normal implantation events. Fertil Steril. 1995;64(1):132–138.
Fouladi-Nashta AA, Raheem KA, Marei WF, Ghafari F, Hartshorne GM. Regulation and roles of the hyaluronan system in mammalian reproduction. Reproduction. 2017;153(2):R43–R58.
Zhang C, Duan E, Cao Y, Jiang G, Zeng G. Effect of 32/67 kDa laminin-binding protein antibody on mouse embryo implantation. J Reprod Fertil. 2000;119(1):137–142.
Klemmt PA, Carver JG, Koninckx P, McVeigh EJ, Mardon HJ. Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Hum Reprod. 2007;22(12):3139–3147.
Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
Jerzak M, Rechberger T, Górski A. Intravenous immunoglobulin therapy influences T cell adhesion to extracellular matrix in women with a history of recurrent spontaneous abortions. Am J Reprod Immunol. 2000;44(6):336–341.
Ozawa F, Mori R, Obayashi Y, et al. Clinical significance of MMPs (matrix metalloproteinases) and TIMPs (tissue inhibitors of metalloproteinases) with recurrent miscarriage. Nagoya: The 71st Annual Congress of the Japan Society of Obstetrics and Gynecology, 2019.
Endo T, Kiya T, Goto T, et al. Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus. Reprod Med Biol. 2006;5(4):235–243.
Vos MC, van der Wurff AA, Last JT, et al. Immunohistochemical expression of MMP-14 and MMP-2, and MMP-2 activity during human ovarian follicular development. Reprod Biol Endocrinol. 2014;12:12.
Riley SC, Thomassen R, Bae SE, Leask R, Pedersen HG, Watson ED. Matrix metalloproteinase-2 and-9 secretion by the equine ovary during follicular growth and prior to ovulation. Anim Reprod Sci. 2004;81(3–4):329–339.
McCord L, Park E, Jo M, Brannstrom M, Curry TE. Expression of matrix metalloproteinase 10 (Mmp10) during the periovulatory period. Biol Reprod. 2010;83(Suppl_1):642.
Amargant F, Manuel SL, Tu Q, et al. Ovarian stiffness increases with age in the mammalian ovary and depends on collagen and hyaluronan matrices. Aging Cell. 2020;19(11):e13259.
Irving-Rodgers HF, Rodgers RJ. Extracellular matrix in ovarian follicular development and disease. Cell Tissue Res. 2005;322(1):89–98.
Irving-Rodgers HF, Mussard ML, Kinder JE, Rodgers RJ. Composition and morphology of the follicular basal lamina during atresia of bovine antral follicles. Reproduction. 2002;123(1):97–106.
Jankowska K. Premature ovarian failure. Menopause Rev. 2017;16(2):51–56.
Zhou F, Shi LB, Zhang SY. Ovarian fibrosis: a phenomenon of concern. Chin Med J (Engl). 2017;130(3):365–371.
Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
Lewandowski KC, Komorowski J, O’Callaghan CJ, et al. Increased circulating levels of matrix metalloproteinase-2 and-9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):1173–1177.
Xu L, Ding L, Wang L, et al. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars. Stem Cell Res Ther. 2017;8(1):84.
Cao Y, Sun H, Zhu H, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9(1):192.
Zhang Y, Shi L, Lin X, et al. Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study. Stem Cell Res Ther. 2021;12(1):420.
Oktem O, Oktay K. The role of extracellular matrix and activin-A in in vitro growth and survival of murine preantral follicles. Reprod Sci. 2007;14(4):358–366.
Heymann D, Vidal L, Or Y, Shoham Z. Hyaluronic acid in embryo transfer media for assisted reproductive technologies. Cochrane Database Syst Rev. 2020;9(9):CD007421.
Shakouri-Motlagh A, O’Connor AJ, Brennecke SP, Kalionis B, Heath DE. Native and solubilized decellularized extracellular matrix: a critical assessment of their potential for improving the expansion of mesenchymal stem cells. Acta Biomater. 2017;55:1–12.
Miyazaki K, Maruyama T. Partial regeneration and reconstruction of the rat uterus through recellularization of a decellularized uterine matrix. Biomaterials. 2014;35(31):8791–8800.
Miki F, Maruyama T, Miyazaki K, et al. The orientation of a decellularized uterine scaffold determines the tissue topology and architecture of the regenerated uterus in rats. Biol Reprod. 2019;100(5):1215–1227.
Padma AM, Tiemann TT, Alshaikh AB, Akouri R, Song MJ, Hellström M. Protocols for rat uterus isolation and decellularization: applications for uterus tissue engineering and 3D cell culturing. Methods Mol Biol. 2018;1577:161–175.
Pors SE, Ramløse M, Nikiforov D, et al. Initial steps in reconstruction of the human ovary: survival of pre-antral stage follicles in a decellularized human ovarian scaffold. Hum Reprod. 2019;34(8):1523–1535.
Oktay K, Bedoschi G, Pacheco F, Turan V, Emirdar V. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery. Am J Obstet Gynecol. 2016;214(1):94.e1–94.e9.
Vanacker J, Luyckx V, Dolmans MM, et al. Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials. 2012;33(26):6079–6085.
Choi JK, Agarwal P, Huang H, Zhao S, He X. The crucial role of mechanical heterogeneity in regulating follicle development and ovulation with engineered ovarian microtissue. Biomaterials. 2014;35(19):5122–5128.
Jamalzaei P, Rezazadeh Valojerdi M, Montazeri L, Baharvand H. Applicability of hyaluronic acid-alginate hydrogel and ovarian cells for in vitro development of mouse preantral follicles. Cell J. 2020;22(Suppl 1):49–60.
Arora B, Tandon R, Attri P, Bhatia R. Chemical crosslinking: role in protein and peptide science. Curr Protein Pept Sci. 2017;18(9):946–955.
Koide T, Daito M. Effects of various collagen crosslinking techniques on mechanical properties of collagen film. Dent Mater J. 1997;16(1):1–9.
Reddy N, Reddy R, Jiang Q. Crosslinking biopolymers for biomedical applications. Trends Biotechnol. 2015;33(6):362–369.
Jiang Q, Reddy N, Yang Y. Cytocompatible cross-linking of electrospun zein fibers for the development of water-stable tissue engineering scaffolds. Acta Biomater. 2010;6(10):4042–4051.
Delgado LM, Bayon Y, Pandit A, Zeugolis DI. To cross-link or not to cross-link? Cross-linking associated foreign body response of collagenbased devices. Tissue Eng Part B Rev. 2015;21(3):298–313.
Kobayashi T, Chanmee T, Itano N. Hyaluronan: metabolism and function. Biomolecules. 2020;10(11):1525.
Segura T, Anderson BC, Chung PH, Webber RE, Shull KR, Shea LD. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials. 2005;26(4):359–371.
Lou J, Stowers R, Nam S, Xia Y, Chaudhuri O. Stress relaxing hyaluronic acid-collagen hydrogels promote cell spreading, fiber remodeling, and focal
adhesion formation in 3D cell culture. Biomaterials. 2018;154:213–222.
Ge F, Lu Y, Li Q, Zhang X. Decellularized extracellular matrices for tissue engineering and regeneration. Adv Exp Med Biol. 2020;1250:15–31.
Liu C, Pei M, Li Q, Zhang Y. Decellularized extracellular matrix mediates tissue construction and regeneration. Front Med. 2022;16(1):56–82.
Ma B, Wang X, Wu C, Chang J. Crosslinking strategies for preparation of extracellular matrix-derived cardiovascular scaffolds. Regen Biomater. 2014;1(1):81–89.
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–736.
Talovic M, Patel K, Schwartz M, Madsen J, Garg K. Decellularized extracellular matrix gelloids support mesenchymal stem cell growth and function in vitro. J Tissue Eng Regen Med. 2019;13(10):1830–1842.
Lai Y, Sun Y, Skinner CM, et al. Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding largescale highly functional human mesenchymal stem cells. Stem Cells Dev. 2010;19(7):1095–1107.
Lin H, Yang G, Tan J, Tuan RS. Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials. 2012;33(18):4480–4489.
Dunn A, Talovic M, Patel K, Patel A, Marcinczyk M, Garg K. Biomaterial and stem cell-based strategies for skeletal muscle regeneration. J Orthop Res. 2019;37(6):1246–1262.
Caliari SR, Burdick JA. A practical guide to hydrogels for cell culture. Nat Methods. 2016;13(5):405–414.
Cao H, Duan L, Zhang Y, Cao J, Zhang K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther. 2021;6(1):426.
Huang Q, Zou Y, Arno MC, et al. Hydrogel scaffolds for differentiation of adipose-derived stem cells. Chem Soc Rev. 2017;46(20):6255–6275.
Lv H, Wu B, Song J, Wu W, Cai W, Xu J. Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions. J Mater Chem B. 2021;9(33):6536–6552.
Chan M, Keane T, Jones B, Smith JR, Stevens M, Saso S. Bioengineering approaches for female fertility preservation and infertility treatment. BJOG. 2019;126(S2):196.
Nikukar H. Regenerative medicine for female reproductive system. Accessed January 12, 2023. http://ijrm.ir/browse.php?mag_id=163&slc_lang=en&sid=1
Yoshimasa Y, Maruyama T. Bioengineering of the uterus. Reprod Sci. 2021;28(6):1596–1611.
Xin L, Lin X, Pan Y, et al. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility. Acta Biomater. 2019;92:160–171.
Donnez J, Dolmans MM. Fertility Preservation in Women. N Engl J Med. 2017;377(17):1657–1665.
Downloads
Published
Issue
Section
Downloads
License
Copyright (c) 2023 Placenta and Reproductive Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
